Cioffi Melina
SEC CIK 2066841 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP, Regulatory Affairs | 273.2K | — | $105.5K | 5 | 2025-05-15 | 2026-05-15 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 12:36 | 2026-05-15 | AQST | Aquestive Therapeutics, Inc. | Cioffi Melina | SVP, Regulatory Affairs | F - Tax | $4.17 | -1,667 | 273.2K | -0.6% | -$6,951 | |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | Cioffi Melina | SVP, Regulatory Affairs | S - Sale | $4.17 | -25.3K | 274.9K | -8% | -$105.5K |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Cioffi Melina | SVP, Regulatory Affairs | A - Grant | $0.00 | +100.0K | 300.2K | +50% | $0 |
| 2025-12-04 | 2025-12-02 | AQST | Aquestive Therapeutics, Inc. | Cioffi Melina | SVP, Regulatory Affairs | F - Tax | $5.93 | -2,083 | 200.2K | -1% | -$12.4K | |
| 2025-05-15 | 2025-05-15 | AQST | Aquestive Therapeutics, Inc. | Cioffi Melina | SVP, Regulatory Affairs | A - Grant | $0.00 | +20.0K | 202.3K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations